Transparency on trial

(Image: Getty/css0101)

FDA update on COVID-19 actions and advisements

By Jenni Spinner

Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.

(Image: Getty/Shidlovski)

Judge: Feds must open trial data access

By Jenni Spinner

A judge has ruled in favor of parties seeking to broaden access to federal clinical trial information, helping close a long-standing loophole.

(Image: Getty/Ivanmollov)

The potential of blockchain for clinical trials

By Ben Hargreaves

Due to the imperative for secure communication between stakeholders organizing clinical trials, a recent report suggests that blockchain technology could be a ‘perfect’ solution.

(Image: Getty/z_wei)

Sponsors need to understand and prepare for CCPA: Greenphire

By Melissa Fassbender

California’s data privacy law will provide clinical trial participants with confidence that their information will not be misused – though additional clarity is needed as the pharmaceutical industry faces mounting pressure to increase transparency.

Follow us

Products

View more

Webinars